BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18359942)

  • 41. Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR
    Thompson D; Mahmood S; Morrice N; Kamli-Salino S; Dekeryte R; Hoffmann PA; Doherty MK; Whitfield PD; Delibegović M; Mody N
    Sci Rep; 2023 Mar; 13(1):3937. PubMed ID: 36894641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apoptotic sphingolipid signaling by ceramides in lung endothelial cells.
    Medler TR; Petrusca DN; Lee PJ; Hubbard WC; Berdyshev EV; Skirball J; Kamocki K; Schuchman E; Tuder RM; Petrache I
    Am J Respir Cell Mol Biol; 2008 Jun; 38(6):639-46. PubMed ID: 18192502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels.
    Barnard SA; Pieters M; De Lange Z
    Blood Rev; 2016 Nov; 30(6):421-429. PubMed ID: 27233154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha?
    Cigolini M; Tonoli M; Borgato L; Frigotto L; Manzato F; Zeminian S; Cardinale C; Camin M; Chiaramonte E; De Sandre G; Lunardi C
    Atherosclerosis; 1999 Mar; 143(1):81-90. PubMed ID: 10208482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of exercise duration on the key pathways of ceramide metabolism in rat skeletal muscles.
    Błachnio-Zabielska A; Baranowski M; Zabielski P; Górski J
    J Cell Biochem; 2008 Oct; 105(3):776-84. PubMed ID: 18680146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue.
    Kolak M; Gertow J; Westerbacka J; Summers SA; Liska J; Franco-Cereceda A; Orešič M; Yki-Järvinen H; Eriksson P; Fisher RM
    Lipids Health Dis; 2012 Sep; 11():115. PubMed ID: 22974251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanisms of tumor necrosis factor-alpha-mediated plasminogen activator inhibitor-1 expression in adipocytes.
    Pandey M; Loskutoff DJ; Samad F
    FASEB J; 2005 Aug; 19(10):1317-9. PubMed ID: 15928193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sphingolipids in skeletal muscles of C57B1/6 mice after short-term simulated microgravity].
    Bryndina IG; Shalagina MN; Ovechkin SV; Ovchinina NG
    Ross Fiziol Zh Im I M Sechenova; 2014 Nov; 100(11):1280-6. PubMed ID: 25665406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
    Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
    Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
    Skurk T; Hauner H
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance.
    Ussher JR; Folmes CD; Keung W; Fillmore N; Jaswal JS; Cadete VJ; Beker DL; Lam VH; Zhang L; Lopaschuk GD
    PLoS One; 2012; 7(5):e37703. PubMed ID: 22629445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.
    Samad F; Yamamoto K; Loskutoff DJ
    J Clin Invest; 1996 Jan; 97(1):37-46. PubMed ID: 8550848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1.
    Samad F; Uysal KT; Wiesbrock SM; Pandey M; Hotamisligil GS; Loskutoff DJ
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6902-7. PubMed ID: 10359811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.
    Fillmore N; Keung W; Kelly SE; Proctor SD; Lopaschuk GD; Ussher JR
    Exp Physiol; 2015 Jun; 100(6):730-41. PubMed ID: 25786668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutrophil elastase increases airway ceramide levels via upregulation of serine palmitoyltransferase.
    Karandashova S; Kummarapurugu AB; Zheng S; Chalfant CE; Voynow JA
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L206-L214. PubMed ID: 29025713
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways.
    Pewzner-Jung Y; Park H; Laviad EL; Silva LC; Lahiri S; Stiban J; Erez-Roman R; Brügger B; Sachsenheimer T; Wieland F; Prieto M; Merrill AH; Futerman AH
    J Biol Chem; 2010 Apr; 285(14):10902-10. PubMed ID: 20110363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.
    Giles C; Takechi R; Mellett NA; Meikle PJ; Dhaliwal S; Mamo JC
    J Neurochem; 2017 May; 141(3):413-422. PubMed ID: 28129448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1.
    Kim SH; Park HS; Hong MJ; Yoo JY; Lee H; Lee JA; Hur J; Kwon DY; Kim MS
    J Ethnopharmacol; 2016 Nov; 192():201-209. PubMed ID: 27404230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines.
    Halleux CM; Declerck PJ; Tran SL; Detry R; Brichard SM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4097-105. PubMed ID: 10566656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
    Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
    Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.